Clearside Biomedical Inc (CLSD)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -48.895 | -94.13 | -195.757 | -86.803 | -79.006 | 1.209 | -69.947 | -76.148 |
Return on Equity (%) | -147.897 | -126.727 | -367.794 | -176.956 | -182.831 | 1.609 | -135.635 | 1224.694 |
Return on Invested Capital (%) | -109.533 | -111.615 | -283.718 | -128.219 | -155.154 | -2.707 | -125.132 | 926.151 |
Operating Margin (%) | -4977.308 | -17094.203 | -276060 | -1416.015 | -230.682 | 1.271 | -2231.198 | -281.121 |
Net Profit Margin (%) | -4977.308 | -17094.203 | -276060 | -1416.015 | -230.682 | 1.271 | -2482.818 | -394.906 |
Book Value Per Share | 2.916 | 0.845 | 0.735 | 0.251 | 0.169 | 0.636 | 0.175 | -0.255 |
Earnings Per Share | -1.053 | -2.326 | -2.578 | -0.693 | -0.351 | 0.006 | -0.543 | -0.521 |
Cash Per Share | 1.417 | 0.364 | 0.25 | 0.509 | 0.333 | 0.51 | 0.796 | 0.463 |
Working Capital Per Share | 3.211 | 1.013 | 1.011 | 0.322 | 0.158 | 0.628 | 0.719 | 0.374 |
Operating Profit Per Share | 0.021 | 0.014 | 0.001 | 0.049 | 0.152 | 0.495 | 0.021 | 0.126 |
EBIT Per Share | -1.053 | -2.326 | -2.578 | -0.693 | -0.351 | 0.006 | -0.543 | -0.521 |
EBITDA Per Share | -1.053 | -2.326 | -2.578 | -0.693 | -0.351 | 0.006 | -0.543 | -0.521 |
Free Cash Flow Per Share | -1.056 | -2.321 | -2.582 | -0.697 | -0.354 | 0.003 | -0.542 | -0.493 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 24,57M | 25,36M | 32,12M | 44,41M | 51,86M | 59,72M | 60,64M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 60,64M | N/A | 61,72M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -177825 | N/A | N/A | N/A | -4069.565 | N/A | N/A |
Net Profit Margin (%) | N/A | -232000 | N/A | N/A | N/A | -5114.348 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 70,53M |
Ratio cours/bénéfice | -2,22 |
Ratio prix/ventes | 8,76 |
Ratio prix/liquidités | 2,49 |
Ratio prix/valeur comptable | -4,53 |
Rendement de dividende | - |
Actions en circulation | 75,84M |
Volume moyen (1 semaine) | 575,2k |
Volume moyen (1 mois) | 325,94k |
Variation sur 52 semaines | -18,24% |
Plus haut sur 52 semaines | 2,12 |
Plus bas sur 52 semaines | 0,801 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales